Northwestern Medicine investigators have developed first-of-its-kind eyedrops that use synthetic nanoparticles to help the ...

Q1 2025 Earnings Call Transcript May 6, 2025 Krystal Biotech, Inc. misses on earnings expectations. Reported EPS is $1.2 EPS, expectations were $1.38. Operator: Thank you for standing by, and welcome ...

How chronic anger silently shortens your lifespan by accelerating aging and increasing disease risk across heart, brain, and ...

Elmhurst Hospital, owned by Endeavor Health, will be closing its specialty Wound Care clinic this summer, according to a ...

The Company intends to use net proceeds from the Offering for expansion into new markets, R&D activities to expand its product portfolio, research and development activities, building brand awareness, ...

Knee trauma can lead to severe complications like chronic osteomyelitis, as shown in this rare paediatric case, which ...

Discover the causes, symptoms, and effective treatments for sores on the bottom of your feet. Find relief and prevent future ...

Discover how smart bandages revolutionise wound care - read more about breakthrough infection detection and healing ...

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...

AMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM®, the flagship product of DEBx Medical has been awarded the IIWCG ...

Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa ...

FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.